<?xml version="1.0" encoding="UTF-8"?>
<p>Treatment with (-)-fenchone at its most effective dose (150 mg/kg, p.o.) significantly reduced the percentage of intestinal transit to 37% when compared to the negative control group (85%). In the group pretreated with pilocarpine (non-selective muscarinic receptor agonist, 1 mg/kg, i.p.), fenchone significantly reduced muscarinic action in intestinal transit to 75% (Figure 
 <xref ref-type="fig" rid="F3">3</xref>).
</p>
